Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

PHASE2UnknownINTERVENTIONAL
Timeline

Start Date

December 31, 1999

Conditions
Lymphoma
Interventions
BIOLOGICAL

filgrastim

BIOLOGICAL

rituximab

DRUG

cyclophosphamide

DRUG

doxorubicin hydrochloride

DRUG

prednisone

DRUG

vincristine sulfate

Trial Locations (27)

10466

Our Lady of Mercy Medical Center, The Bronx

11235

HemOnCare, P.C., Brooklyn

20850

Associates in Oncology and Hematology, Rockville

23226

Hematology & Oncology Associates of Virginia, Richmond

28603

N.W. Carolina Oncology & Hematology, P.A., Hickory

32501

Hematology-Oncology Associates, PA, Pensacola

33140

Mount Sinai Comprehensive Cancer Center, Miami Beach

33176

Oncology-Hematology Group of South Florida, Miami

33308

Southeast Florida Hematology-Oncology Group, Fort Lauderdale

36106

Montgomery Cancer Center, Montgomery

38163

University of Tennessee, Memphis, Memphis

41017

Hematology/Oncology Care Inc., Crestview Hills

45219

Oncology/Hematology Care, Inc., Cincinnati

48202

Henry Ford Hospital, Detroit

49085

Lakeland Medical Center - St. Joseph, Saint Joseph

63136

Midwest Hematology Oncology Consultants, Ltd., St Louis

65401

Bond Clinic, Rolla

67502

Hutchinson Clinic, P.A., Hutchinson

72205

University of Arkansas for Medical Sciences, Little Rock

84124

Intermountain Hematology/Oncology Associates, Inc., Salt Lake City

87109

New Mexico Oncology-Hematology, Albuquerque

91505

Providence Saint Joseph Medical Center - Burbank, Burbank

92270

Cancer and Blood Institute of the Desert, Rancho Mirage

04074

Maine Center for Cancer Medicine and Blood Disorders, Scarborough

01960

North Shore Cancer Center, Peabody

07962

Hematology Oncology Associates, Morristown

05446

Vermont Center for Cancer Medicine, Inc., Colchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY